ARCHIVES

CTI Files Appeal Over FDA’s Decision on Pixantrone

This article is from The Cancer Letter archive.

Vol. 36 No. 44 | December 3, 2010

Download PDF Visit The Full Archive

Related Articles

Study Shows MammaPrint Test Can Predict 25-Year Risk Levels

February 28, 2014

CPT Code Changes Confuse Oncologists, Appear To Bloc Some Chemotherapy Payments

April 6, 1990

Herceptin Regimen Minus Adriamycin Increases Survival With Less Toxicity

October 28, 2011

NCI Officials Open To Fine-Tuning Group Budgets As Advocates Chip Away At NCTN’s Façade

May 2, 2014

In Brief: Hendrix To Head Children’s Memorial Institute

June 20, 2003

ACS Modifies Mammography Guidelines

August 5, 1983